Cholestyramine

Common brands: Questran, Prevalite, Cholestyramine Light, Vitamin D, Acid Reducer

Top reporter: Endo Usa, Inc.

Bile Acid Sequestrant [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
11,789
Total Reports
4,812
Serious Reports
828
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.02%)

Patient Demographics

Male
4,034
Female
6,783

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cholestyramine.

# Reaction Reports % of Total
1 DIARRHOEA 1,662
10.8%
2 OFF LABEL USE 1,083
7.0%
3 DRUG INEFFECTIVE 921
6.0%
4 FATIGUE 890
5.8%
5 NAUSEA 802
5.2%
6 ARTHRALGIA 627
4.1%
7 HEADACHE 556
3.6%
8 ABDOMINAL PAIN 538
3.5%
9 VOMITING 515
3.3%
10 WEIGHT DECREASED 502
3.3%
11 DYSPNOEA 500
3.2%
12 PAIN 480
3.1%
13 ASTHENIA 458
3.0%
14 CONSTIPATION 398
2.6%
15 MALAISE 395
2.6%
16 DIZZINESS 379
2.5%
17 PNEUMONIA 377
2.4%
18 PRURITUS 376
2.4%
19 COUGH 373
2.4%
20 FALL 362
2.3%
21 CROHN^S DISEASE 357
2.3%
22 CONDITION AGGRAVATED 352
2.3%
23 DEATH 348
2.3%
24 PAIN IN EXTREMITY 322
2.1%
25 PYREXIA 319
2.1%
26 RASH 319
2.1%
27 DECREASED APPETITE 314
2.0%
28 BACK PAIN 310
2.0%
29 DEHYDRATION 291
1.9%
30 URINARY TRACT INFECTION 288
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.